Rounds / ANRis
A
ANRis raises ¥220M (Undisclosed)
siRNA design technology to selectively silence mutant genes.
- Company
- ANRis
- Reported
- 7 Sept 2026 · that week's brief
- Stage
- Undisclosed · Other
- Amount
- ¥220M1 · as announced: 「約2億2,000万円」
- Breakdown
- Equity ¥220MEquity presumed
- Status
- In scopeNot yet registry-confirmed
- Investors
- Waseda University VenturesJapan Science and Technology Agency
- Sector
- BiotechDeep tech
- Source
- Primary release (PR TIMES) · BRIDGE coverage
1 ≈ ~$1.42M at the ECB reference rate on 2026-09-07 (¥1 = $0.00646). Yen is the figure of record. Methodology
Get the weekly brief
Every Japanese funding round worth knowing, in one English email. Free. Subscribe on Substack →
Every Japanese funding round worth knowing, in one English email. Free. Subscribe on Substack →